BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,209,795 | +4.3% | 100,526 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,078,106 | -34.6% | 100,526 | -16.5% | 0.00% | -25.0% |
| Q4 2022 | $4,708,844 | -23.9% | 120,400 | -7.3% | 0.00% | -33.3% |
| Q3 2022 | $6,188,000 | +80.5% | 129,888 | +46.7% | 0.01% | +100.0% |
| Q2 2022 | $3,428,000 | -39.3% | 88,557 | -10.1% | 0.00% | -25.0% |
| Q1 2022 | $5,647,000 | -28.3% | 98,560 | -0.2% | 0.00% | -20.0% |
| Q4 2021 | $7,871,000 | -18.6% | 98,766 | -11.2% | 0.01% | -28.6% |
| Q3 2021 | $9,675,000 | -28.7% | 111,199 | +5.5% | 0.01% | -30.0% |
| Q2 2021 | $13,564,000 | +64.2% | 105,386 | +2.1% | 0.01% | +66.7% |
| Q1 2021 | $8,262,000 | +10.0% | 103,223 | +12.2% | 0.01% | 0.0% |
| Q4 2020 | $7,509,000 | +281.2% | 91,982 | +15.0% | 0.01% | +200.0% |
| Q3 2020 | $1,970,000 | +159.2% | 80,016 | +194.7% | 0.00% | +100.0% |
| Q2 2020 | $760,000 | – | 27,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |